Found 66 matching trials
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies N/A A surveillance of respiratory tract related adverse events in patients trea...
Show More Location
Cardiovascular Associates, P.C.
Learn More & Join Trial
Iloprost in High Risk Cardiac Surgical Patients PHASE3 In this study effects of the intra operative, prophylactic inhalation of Il...
Show More Location
Hospital of the university of Aachen
Learn More & Join Trial
Iloprost Power 15 in Pulmonary Arterial Hypertension PHASE3 Patients with symptomatic idiopathic pulmonary arterial hypertension (IPAH)...
Show More Location
Multiple Locations
Learn More & Join Trial
Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension N/A Local, prospective, multicenter, non-comparative, non-interventional, obser...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Iloprost on Pulmonary Oxygenation in Patients With Low Diffusing Capacity During One-lung Ventilation NA One lung ventilation (OLV) is essential during thoracic surgery. During OLV...
Show More Location
Department of Anaesthesiology and Pain Medicine, Anaesthesia and Pain Research Institute, Yonsei University College of Medicine
Learn More & Join Trial
Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD) NA The investigators believe that iloprost will improve gas exchange in COPD p...
Show More Location
University of Oklahoma Health Sciences Center
Learn More & Join Trial
Efficacy of Ventavis Used in Real-life Setting. N/A This is a registry of patients diagnosed with pulmonary arterial hypertensi...
Show More Location
Multiple Locations
Learn More & Join Trial
Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years N/A This is an open-label, uncontrolled, prospective long-term observation of S...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects PHASE4 This is a 24-month, multi-center, prospective, open-label, safety evaluatio...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20) N/A The aim of this study is to examine inhalation behavior in patients enrolle...
Show More Location
Multiple Locations
Learn More & Join Trial